You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九典制藥(300705.SZ):利多卡因凝膠貼膏已申報生產,另還有多個品種處於臨牀前研究或立項階段
格隆匯 05-16 20:28

格隆匯5月16日丨九典制藥(300705.SZ)於2023年5月16日下午14:00-15:00接受特定對象調研,就“近期公司開展臨牀的外用製劑品種比較多,後續產品的研發進展和上市節奏如何?”,公司回覆稱,利多卡因凝膠貼膏已申報生產,吲哚美辛凝膠貼膏、洛索洛芬鈉凝膠貼膏、氟比洛芬凝膠貼膏、椒七麝凝膠貼膏、PDX-02、PDX-03正在開展臨牀,酮洛芬貼劑和氟比洛芬貼劑已獲批臨牀。另還有多個品種處於臨牀前研究或立項階段。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account